期刊文献+

右美托咪啶用于55例2型糖尿病患者麻醉的临床效果探究 被引量:2

Study on Clinical Effect of Dexmedetomidine in the Anesthesia of 55 Cases with Type 2 Diabetes
下载PDF
导出
摘要 目的就2型糖尿病患者麻醉期间的应用右美托咪啶的临床效果予以分析探讨。方法选取该院2016年1—12月收治的55例接受全身麻醉手术的2型糖尿病患者为研究对象,随机将其分为对照组(25例)与试验组(30例),对照组在手术麻醉期接受静脉生理盐水注射,试验组接受静脉右美托咪啶注射,对两组患者的麻醉效果进行比较。结果通过比较患者各阶段MAP和HR的数据值(注射时、插管时、手术切皮时、手术开始5 min、10 min、15 min、30 min、拔管前、拔管时、拔管后5 min和10 min)得出,试验组患者明显比对照组患者情况要好,差异有统计学意义(P<0.05)。结论将右美托咪啶应用于2型糖尿病患者的麻醉手术中临床疗效非常显著,不会对患者术中的各项数据值产生较大的影响,让手术顺利进行下去,临床价值较高。 Objective To analyze and study the clinical effect of dexmedetomidine in the anesthesia of type2diabetes.Methods55cases of type2diabetes patients with general anesthesia surgery admitted and treated in our hospital from January to December2016were selected as the research objects and randomly divided into two groups,the control group with25cases used the intravenous injection of normal saline during the operative anesthesia period,while the test group adopted the intravenous injection of dexmedetomidine,and the anesthesia effect was compared between the two groups.Results The MAP and HR values at various phases(at injection,at intubation,at operation incision,in5min,10min,15min,30min after surgery,before intubation,at intubation and in5min and10min after intubation)showed that the situation in the test group was better than that in the control group,and the difference was statistically significant(P<0.05).Conclusion The clinical curative effect of dexmedetomidine in the anesthesia of type2diabetes is very obvious,which can not have a bigger effect on various data values,and it makes the operation conducted successfully,and the clinical value is higher.
作者 蔡爱香 黄同玲 CAI Ai-xiang;HUANG Tong-ling(Ningde Hospital Affiliated to Fujian Medical University, Ningde, Fujian Province, 325100 China)
出处 《糖尿病新世界》 2017年第20期67-68,共2页 Diabetes New World Magazine
关键词 右美托咪啶 2型糖尿病 麻醉 Dexmedetomidine Type 2 diabetes Anesthesia
  • 相关文献

参考文献3

二级参考文献23

  • 1张兴安,芮建中,吴群林,施冲,王若松.NONMEM法分析静滴异丙酚在中国人体的群体药代动力学[J].中国临床药理学杂志,2004,20(6):444-448. 被引量:34
  • 2佘守章,李慧玲,许学兵,莫世湟.右旋美托咪啶的镇静效应及其对全麻镇静深度的影响[J].临床麻醉学杂志,2006,22(1):10-12. 被引量:105
  • 3TAKAHASHI S, UCHINO H, SHIMIZU T, et al. Comparison of glycated albumin (GA) and glycated hemoglobin(HbA10) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control[J]. Endocr J, 2007, 54 (1): 139- 144.
  • 4MOGENSEN CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes [J]. N Eng J Med, 1984, 310(6): 356-601.
  • 5WILKINSON CP, FERRIS FL 3rd, KLEIN RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales [J]. Ophthalmology, 2003, 110 (9) : 1677-1682.
  • 6KOGA M, MATSUMOTO S, SAITO H, et al. Body mass index negatively influence glycated albumin, but not glycated hemoglobin, in diabetic patients [J]. Endocr J, 2006, 53(3): 387-391.
  • 7MIYASHITA Y, NISHIMURA R, MORIMOTO A, et al. Glycated albumin is low in obese, type 2 diabetic patients [J]. Diabetes Res Clin Pract, 2007, 78(1 ): 51-55.
  • 8NISHIMURA R, KANDA A, SANO H, et al. Glycated albumin is low in obese, non-diabetic children [J]. Diabetes Res Clin Pract, 2006, 71(3): 334-338.
  • 9HOLMAN RR, PAUL SK, BETHEl MA, et al. 10-year follow- up of intensive glucose control in type 2 diabetes [J]. N Engl J Med, 2008, 359(15) : 1577-1589.
  • 10COHEN MP, CHEN S, ZIYADEH FN, et al. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy [J]. Kidney Int, 2005, 68(4): 1554-1561.

共引文献27

同被引文献24

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部